Significance of galectins-1, -3, -4 and -7 in the progression of squamous cell carcinoma of the tongue

Pathology Research and Practice

Volumn 207, Issue 4, 2011, Pages 236-240

  Alves, Pollianna M ^a   Godoy, Gustavo P ^a   Gomes, Daliana Q ^a   Medeiros, Ana Miryam C ^b   De Souza, Lélia B ^b   Da Silveira, Ericka J D ^b   Vasconcelos, Marcelo G ^b   Queiroz, Lélia M G ^b  

^a Paraiba State University UEPB   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Galectins; Immunohistochemistry; Oral carcinogenesis; Squamous cell carcinoma of the tongue

Indexed keywords

GALECTIN 1; GALECTIN 3; GALECTIN 4; GALECTIN 7;

ADULT; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METASTASIS POTENTIAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA;

ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; FEMALE; GALECTIN 1; GALECTIN 3; GALECTIN 4; GALECTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; TONGUE; TONGUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79955154452     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.02.004     Document Type: Article

References (23)

1. Noel A., Foidart J.M. The role of stroma in breast carcinoma growth in vivo. J. Mammary Gland Biol. Neoplasia 1998, 3:215-225.
2. Scully C., Bagan J. Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications. Oral Dis. 2009, 15:388-399.
3. Kademani D., Bell R.B., Bagheri S., Holmgren E., Dierks E., Potter B., Homer L. Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade. J. Oral Maxillofac. Surg. 2005, 63:1599-1605.
4. Silveira E.J., Godoy G.P., Lins R.D., Arruda M.L.M.L.S., Ramos C.C., Freitas R.A., Galvao H.C. Correlation of clinical, histological, and cytokeratin profiles of squamous cell carcinoma of the oral tongue with prognosis. Int. J. Surg. Pathol. 2007, 15:376-383.
5. Liu F.T., Rabinovich G.A. Galectins as modulators of tumour progression. Nat. Rev. Cancer 2005, 5:29-41.
6. Grandis J.R., Pietenpol J.A., Greenberger J.S., Pelroy R.A., Mohla S.S. Head and neck cancer: meeting summary and research opportunities. Cancer Res. 2004, 64:8126-8129.
7. Lee J.W., Song S.Y., Choi J.J., Choi C.H., Kim T.J., Kim J., Lee J.H., Kim B.G., Bae D.S. Decreased galectin-3 expression during the progression of cervical neoplasia. J. Cancer Res. Clin. Oncol. 2005, 132:241-274.
8. Choi K.K., Kim M.J., Yun P.Y., Lee J.H., Moon H.S., Lee T.R., Myoung H. Independent prognostic factors of 861 cases of oral squamous cell carcinoma in Korean adults. Oral Oncol. 2009, 42:1-10.
9. Bryne M.M. Is the invasive front of an oral carcinoma the most important area for prognostication?. Oral Dis. 1998, 4:70-77.
10. Demers M., Magnaldo T., St-Pierre Y.A. Novel function for galectin-7: promoting tumorigenesis by up-regulating MMP-9 gene expression. Cancer Res. 2005, 65:5205-5210.
11. Johnsen M., Lund L.R., Rømer J., Almholt K., Danø K. Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr. Opin. Cell Biol. 1998, 10:667-671.
12. Piantelli M., Iacobelli S., Almadori G., Iezzi M., Tinari N., Natoli C., Cadoni G., Lauriola L., Ranelletti F.O. Lack of expression of galectin 3 is associated with a poor outcome in node-negative patients with laryngeal squamous cell carcinoma. J. Clin. Oncol. 2002, 20:3850-3856.
13. Huflejt M.E., Leffler H. Galectin 4 in normal tissues and cancer. Glyconj. J. 2004, 20:247-255.
14. Kapucuoglu N., Basak P.Y., Bircan S., Sert S., Akkaya V.B. Immunohistochemical galectin-3 expression in non-melanoma skin cancers. Pathol. Res. Pract. 2009, 205:97-103.
15. Kondoh N., Wakatsuki T., Ryo A., Hada A., Aihara T., Horiuchi S., Goseki N., Matsubara O., Takenaka K., Shichita M., Tanaka K., Shuda M., Yamamoto M.M. Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res. 1999, 59:4990-4996.
16. González-García R., Naval-Gías L., Rodríguez-Campo F.J., Sastre-Pérez J., Muñoz-Guerra M.F., Gil-Díez Usandizaga J.L. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients. J. Oral Maxillofac. Surg. 2008, 66:1390-1398.
17. Yang R.Y., Rabinovich G.A., Liu F.T. Galectins: structure, function and therapeutic potential. Mol. Med. 2008, 10:1-24.
18. Nakahara S., Oka N., Raz A. On the role of galectin-3 in cancer apoptosis. Apoptosis 2005, 10:267-275.
19. Saussez S., Lorfevre F., Lequeux T., Laurent G., Chantrain G., Vertongen F., Toubeau G. The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to the therapy. Oral. Oncol. 2008, 44:86-93.
20. Magnaldo T., Fowlis D., Armon M. Galectin 7 a marker of all types of stratified epithelial. Differentiation 1998, 63:159-168.
21. Than T.H., Swethadri G.K., Wong J., Ahmad T., Jamil D., Maganlal R.K., et al. Expression of galectin-3 and galectin-7 in thyroid malignancy as potential diagnostic indicators. Singapore Med. J. 2008, 49:333-338.
22. Chiang W.F., Liu S.Y., Fang L.Y., Lin C.N., Wu M.H., Chen Y.C., Chen Y.L., Jim Y.T. Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early stage oral squamous cell carcinoma. Oral Oncol. 2008, 44:325-334.
23. Honjo Y., Inohara H., Akahani S., Yoshii T., Takenaka Y., Yoshida J., Hattori K., Tomiyama Y., Raz A., Kubo T. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin. Cancer Res. 2000, 6:4635-4640.